Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera-Reference-Cited by-同舟云学术

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

Published:2020-10 Issue:10 Volume:20 Page:697-703.e1
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Coltoff Alexander,Mesa Ruben^ORCID,Gotlib Jason,Shulman Jessica^ORCID,Rampal Raajit K.,Siwoski Olivia,Yacoub Abdulraheem,Moliterno Alison,Yang Anna,Braunstein Evan,Gerds Aaron T.,Hobbs Gabriela S.,Winton Elliott F.,Goel Swati^ORCID,Wadleigh Martha,Tremblay Douglas^ORCID,Moshier Erin^ORCID,Mascarenhas John

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms;Abelsson;Leuk Lymphoma,2013

2. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia;Elliott;Br J Haematol,2005

3. Complications and causes of death in polycythaemia vera;Chievitz;Acta Med Scand,1962

4. Leukemic transformation in polycythemia vera: analysis of risk factors;Nand;Am J Hematol,1990

5. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study;Tefferi;Leukemia,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice;Annals of Hematology;2024-04-25

2. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis;Annals of Hematology;2024-04-23

3. Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice;2024-01-29

4. A safety evaluation of ruxolitinib for the treatment of polycythemia vera;Expert Opinion on Drug Safety;2023-12-29

5. Weight gain secondary to the use of Janus kinase inhibitors;Archives of Dermatological Research;2023-08-23